{"id":"W2406123041","doi":"10.1016/j.jval.2016.03.1919","title":"TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE: A CANADIAN COST-UTILITY ANALYSIS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tocilizumab; Adalimumab; Etanercept; Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Infliximab; Combination therapy; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004362896,0.001681869,0.002552036,0.00378789,0.001954621,0.003252904,0.002244051,0.001250389,0.005442077],"category_scores_gemma":[0.02194905,0.0009504243,0.005958213,0.008794832,0.001088602,0.001070993,0.001191061,0.00276807,0.0001878024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08808868,"about_ca_system_score_gemma":0.06189725,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9699662,"about_ca_topic_score_gemma":0.9713846,"domain_scores_codex":[0.9957888,0.001561953,0.000235354,0.0002805293,0.001552164,0.0005811522],"domain_scores_gemma":[0.9903386,0.005033466,0.0007664768,0.0002830304,0.002703827,0.0008745963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.06573287,0.002659821,0.3903047,0.01094111,0.03524259,0.00274226,0.001716499,0.1240953,0.002200952,0.024439,0.0916184,0.2483065],"study_design_scores_gemma":[0.02372495,0.003470551,0.6252804,0.003845648,0.05301223,0.002411485,0.002704719,0.2348904,0.0007989441,0.0073163,0.04123441,0.001309976],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8657693,0.0574103,0.003711721,0.009398561,0.000273329,0.002042455,0.0287356,0.0001157595,0.0325431],"genre_scores_gemma":[0.9775503,0.009773105,0.003625305,0.0008619608,0.00006125052,0.0002248694,0.005923572,0.00004697436,0.001932728],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08808868,"threshold_uncertainty_score":0.6391311,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04089977054338074,"score_gpt":0.3187414196124125,"score_spread":0.2778416490690318,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}